Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;20(Supplement):S4-S10.
doi: 10.4103/0971-9784.197790.

Extracorporeal membrane oxygenation for refractory cardiac arrest

Affiliations
Review

Extracorporeal membrane oxygenation for refractory cardiac arrest

Steven A Conrad et al. Ann Card Anaesth. 2017 Jan.

Abstract

Extracorporeal cardiopulmonary resuscitation (ECPR) is the use of rapid deployment venoarterial (VA) extracorporeal membrane oxygenation to support systemic circulation and vital organ perfusion in patients in refractory cardiac arrest not responding to conventional cardiopulmonary resuscitation (CPR). Although prospective controlled studies are lacking, observational studies suggest improved outcomes compared with conventional CPR when ECPR is instituted within 30-60 min following cardiac arrest. Adult and pediatric patients with witnessed in-hospital and out-of-hospital cardiac arrest and good quality CPR, failure of at least 15 min of conventional resuscitation, and a potentially reversible cause for arrest are candidates. Percutaneous cannulation where feasible is rapid and can be performed by nonsurgeons (emergency physicians, intensivists, cardiologists, and interventional radiologists). Modern extracorporeal systems are easy to prime and manage and are technically easy to manage with proper training and experience. ECPR can be deployed in the emergency department for out-of-hospital arrest or in various inpatient units for in-hospital arrest. ECPR should be considered for patients with refractory cardiac arrest in hospitals with an existing extracorporeal life support program, able to provide rapid deployment of support, and with resources to provide postresuscitation evaluation and management.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Growth of extracorporeal cardiopulmonary resuscitation cases reported annually to the Extracorporeal Life Support Organization registry from 1992 to 2015

Similar articles

Cited by

References

    1. Bartlett RH, Roloff DW, Cornell RG, Andrews AF, Dillon PW, Zwischenberger JB. Extracorporeal circulation in neonatal respiratory failure: A prospective randomized study. Pediatrics. 1985;76:479–87. - PubMed
    1. O’Rourke PP, Crone RK, Vacanti JP, Ware JH, Lillehei CW, Parad RB, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: A prospective randomized study. Pediatrics. 1989;84:957–63. - PubMed
    1. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group. Lancet. 1996;348:75–82. - PubMed
    1. O’Rourke PP, Crone RK. Pediatric applications of extracorporeal membrane oxygenation. J Pediatr. 1990;116:393–4. - PubMed
    1. Meliones JN, Custer JR, Snedecor S, Moler FW, O’Rourke PP, Delius RE. Extracorporeal life support for cardiac assist in pediatric patients. Review of ELSO Registry data. Circulation. 1991;84(5 Suppl):III168–72. - PubMed